HomeInsightsPE

Wanbury Ltd PE Ratio

Wanbury Ltd PE Ratio

stocks purchased

₹ 1.9 Cr

Volume Transacted

(Dec 11, 2024)

stocks purchased

58.1 K

Stocks Traded

(Dec 11, 2024)

Last Updated on: Dec 12, 2024

Image

Wanbury Ltd

NSE: WANBURY

PE

38.2

Last updated on: Dec 12, 2024

Key Highlights

  • The P/E Ratio of Wanbury Ltd is 38.2 as of 12 Dec 9.00 AM .
  • The P/E Ratio of Wanbury Ltd changed from 0.7 on March 2020 to 8.5 on March 2024 . This represents a CAGR of 64.76% over 5 years.
  • The Latest Trading Price of Wanbury Ltd is ₹ 322.05 as of 11 Dec 15:30 .
  • The PE Ratio of Pharmaceuticals Industry has changed from 28.2 to 27.1 in 5 years. This represents a CAGR of -0.79%.
  • The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.5. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 157.6. The PE Ratio of Textiles industry is 37.6 in 2024.

Historical P/E Ratio of Wanbury Ltd

No data available

Company Fundamentals for Wanbury Ltd

No data available

Image

Wanbury Ltd

NSE: WANBURY

Share Price

₹ 322.05

15.30 (4.99%)

stock direction

Last updated on: Dec 11, 2024

Market Price of Wanbury Ltd

1M

1Y

3Y

5Y

Monitoring Wanbury Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
11 Dec 2024322.05
10 Dec 2024306.75
09 Dec 2024292.15
06 Dec 2024278.25
05 Dec 2024269.6
04 Dec 2024266.35
03 Dec 2024271.55
02 Dec 2024258.65
29 Nov 2024246.35
28 Nov 2024237.15

SWOT Analysis Of Wanbury Ltd

Strength

1

S

Weakness

1

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Wanbury Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Wanbury Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of P/E Ratio

Company NamePEMarket Cap (INR Cr.)
Wanbury Ltd381,055
Sun Pharmaceuticals Industries Ltd384,35,407
Divis Laboratories Ltd851,57,489
Cipla Ltd251,17,443
Torrent Pharmaceuticals Ltd651,14,197
Mankind Pharma Ltd491,05,098

Key Valuation Metric of Wanbury Ltd

No data available

No data available

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Wanbury Ltd

No data available

* All values are in crore

Historical Revenue of Wanbury Ltd

No data available

* All values are in crore

Historical EBITDA of Wanbury Ltd

No data available

* All values are in crore

Historical Net Profit of Wanbury Ltd

No data available

* All values are in crore

Historical Dividend Payout of Wanbury Ltd

No data available

* All values are in %

About Wanbury Ltd

  • Wanbury Ltd (Formerly known Pearl Organics Limited) was incorporated in August, 1988.
  • The Company is engaged in the business of pharmaceutical and related activities, including research. The company has established its first plant in the year 1992 in Tarapur for manufacturing APIs.
  • In 1995, the Company acquired plant of Brij Chemicals Pvt Ltd at Patalganga.
  • In 1996, it entered into a strategic alliance with Wyckoff Chemicals to manufacture its API in US. In 2007-08, the merger of Doctors Organic Chemicals Limited (DOCL) with the Company became effective from 1st April, 2007.
  • Pursuant to the aforesaid Order of the Hon'ble Bl FR 7,85,557 Equity Shares of face value of Rs. 10/- each of the Company were issued to the Equity Shareholders of DOCL on 17th March, 2008.

Wanbury Ltd News Hub

News

Wanbury consolidated net profit declines 77.83% in the June 2024 quarter

Net profit of Wanbury declined 77.83% to Rs 1.04 crore in the quarter ended June 2024 as a...

Read more

2024-08-13 00:00:00

News

Wanbury to hold board meeting

Wanbury will hold a meeting of the Board of Directors of the Company on 12 August 2024. Po...

Read more

2024-08-08 00:00:00

News

Wanbury to conduct AGM

Wanbury announced that the 36th Annual General Meeting (AGM) of the company will be held o...

Read more

2024-09-11 00:00:00

News

Wanbury consolidated net profit rises 8.97% in the September 2024 quarter

Net profit of Wanbury rose 8.97% to Rs 8.02 crore in the quarter ended September 2024 as a...

Read more

2024-11-14 00:00:00

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of Wanbury Ltd

What is the current PE Ratio of Wanbury Ltd?

The Current PE Ratio of Wanbury Ltd is 38.2 as on 12 Dec 2024.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 40.0 as on 12 Dec 2024.

What was the PE Ratio of Wanbury Ltd last year?

The PE Ratio of Wanbury Ltd was 0.0 last year, now the PE ratio is 38.2, showing a year-on-year growth of -%.

What does the PE Ratio of Wanbury Ltd indicate about its stock?

The PE Ratio of Wanbury Ltd is 38.2. This ratio indicates that investors are willing to pay 38.2 times the earnings per share for each share of Wanbury Ltd.

What is the PE Ratio Growth of Wanbury Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Wanbury Ltd grew by -% whereas, the EPS ratio grew by 662.5.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions